Home JournalsJournal Details
ISSN: 2589-0409 eISSN: 1110-0362 CAS Zone: Medicine (Zone 4) Emerging Zone: Medicine (Zone 4)

Journal of the Egyptian National Cancer Institute

Abbr. J EGYPT NATL CANCER
2.2
Latest IF
Recent Articles
Male breast cancer in Arab populations: a systematic review of molecular, genetic, and clinicopathologic characteristics
Abunasser S, Al-Taweel R, Elnatsheh S et al · Vol 38(1)
2026-09-21
Recent advances in hormone-based biopharmaceuticals for cancer therapy
Sarifulnazwan S, Mohd Tajuddin N, Mohd Nasaruddin S et al · Vol 38(1)
2026-09-21
Epigallocatechin-3-Gallate, the green tea polyphenol suppresses expression of CD31 and VEGFR2 and enhances the chemotherapeutic potential of irinotecan in AOM/DSS model of colorectal cancer in mice
Rahman S, Baruah S, Akhtara N et al · Vol 38(1)
2026-09-17
Correction: Identification of potential biomarkers for oral squamous cell carcinoma through multi-cohort bioinformatic analysis
Kamei D, Kaur S, Priya A et al · Vol 38(1)
2026-09-16
Comparative efficacy and safety of first, second, and third-generation EGFR tyrosine kinase inhibitors in treatment-naïve EGFR-mutant advanced non–small cell lung cancer: a systematic review and network meta-analysis of randomized controlled trials
Mahato S, Mudgal S, Singh H et al · Vol 38(1)
2026-09-14
Performing right upper abdominal cytoreduction: anatomical planes, liver mobilization and occult spaces
Ray M, Rathee A · Vol 38(1)
2026-09-11
Computationally guided multi-epitope vaccine design targeting oncoprotein BZLF1, EBNA1, LMP1, and LMP2 for of EBV associated gastric cancer
Delonio E, Ysrafil Y, Shinta H et al · Vol 38(1)
2026-09-04
Unlocking the potential of bacteriophage-based therapeutic gene delivery in hepatocellular carcinoma
Mitra S, Damini, Devi M et al · Vol 38(1)
2026-09-04
Evaluation of Programmed Death Ligand-1 (PD-L1) and B-cell Lymphoma 2 (BCL2) protein expression using immunohistochemistry in colorectal carcinoma patients from Anbar Governorate
Baraa A, Ahmed H, Mohammed M et al · Vol 38(1)
2026-09-04
Pilot study on RECAF (Receptor for Alpha-Fetoprotein) expression in pediatric acute leukemia: insights from flow cytometry analysis
Youssef S, Mohammady M, Zaiema S · Vol 38(1)
2026-09-02
Multi-omics integration uncovers epigenetic control of metabolic reprogramming in triple-negative breast cancer
Hashem E, Mabrouk M · Vol 38(1)
2026-09-02
Use of indocyanine green fluorescence versus patent blue V dye for sentinel lymph node biopsy in early breast cancer, a randomized controlled trial
Nida M, Abdelmoghny A, Osman A et al · Vol 38(1)
2026-09-02
Nanomedicine strategies for overcoming multidrug resistance in breast cancer: recent advances and future perspectives
Kumar M, Tejaswi, Bangwal R et al · Vol 38(1)
2026-08-26
Head and neck cancer: a comprehensive review of epidemiology, global burden and advances in radiotherapy
A S K, Kumara K S, Kumar A et al · Vol 38(1)
2026-08-22
Nanotechnology-based immunotherapy: integrating Artificial Intelligence (AI) with current strategies in combating brain cancer disease
Roslei A, Huri H, Pratama D et al · Vol 38(1)
2026-08-18
Machine learning and AI for cancer research and care: a review of applications, limitations, and future directions
Yadav K, Gupta T · Vol 38(1)
2026-08-14
From black-box prediction to transparent insight: the status quo and paradigm shift of explainable artificial intelligence in hepatocellular carcinoma research
Li Y, Li P · Vol 38(1)
2026-08-11
Economic evaluation comparing Endobronchial Ultrasound-guided Transbronchial Needle Aspiration (EBUS-TBNA) and surgical mediastinoscopy for mediastinal staging of lung cancer: a systematic review
Anwar Z, Anak Andrew Atoi A, Chan C et al · Vol 38(1)
2026-08-11
Uterine transposition for fertility preservation prior to pelvic irradiation: an initial Egyptian case series
Refky B, Abdelkhalek M, Hamdy M et al · Vol 38(1)
2026-08-11
Identification of potential biomarkers for oral squamous cell carcinoma through multi-cohort bioinformatic analysis
Kamei D, Kaur S, Priya A et al · Vol 38(1)
2026-08-11
Journal Info
ISSN
2589-0409
Abbr.
J EGYPT NATL CANCER
CAS Zone
Medicine (Zone 4) · Non-Top
Emerging Zone
Medicine (Zone 4) · Non-Top
Sub-categories
ONCOLOGYZone 4
Emerging Categories
ONCOLOGYZone 4
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2